AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

SURGICAL INNOVATIONS GROUP PLC

Share Issue/Capital Change Oct 30, 2017

7938_rns_2017-10-30_2c436306-b59a-42f9-a833-26d971db6624.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 9991U

Surgical Innovations Group PLC

30 October 2017

Surgical Innovations Group plc

("SI Group" or the "Company")

Issue of Equity

Surgical Innovations Group plc (AIM: SUN) announces that it has issued and allotted 1,900,000 ordinary shares of 1p each (the "New Shares") following the exercise of options at a price of 1.7p per share by Doug Liversidge, former chairman of the Company.

Application will be made for the New Shares to be admitted to trading on AIM ("Admission") which is expected to take place on 31 October 2017.

Following Admission, the total number of ordinary shares in issue will be 782,363,481 with each share carrying the right to one vote. The above figure may be used by shareholders as the denominator for the purposes of calculating their holding in the Company under the Disclosure Guidance and Transparency Rules.

For further information please contact:

Surgical Innovations Group plc www.sigroupplc.com
Nigel Rogers, Executive Chairman Tel: 0113 230 7597
Melanie Ross, COO & CFO
WH Ireland Limited (NOMAD & Broker) Tel: 0113 394 6600
Tim Feather

Alex Bond
Walbrook PR  (Financial PR & Investor Relations) Tel: 020 7933 8780 or [email protected]
Paul McManus Mob: 07980 541 893
Lianne Cawthorne Mob: 07584 391 303

This information is provided by RNS

The company news service from the London Stock Exchange

END

IOEZBLFXDBFXFBB

Talk to a Data Expert

Have a question? We'll get back to you promptly.